CDSCO Panel Clears AstraZeneca’s Datopotamab for Breast Cancer, Seeks Phase IV Trial

New Delhi: The Subject Expert Committee (SEC) under the Oncology division of the Central Drugs Standard Control Organisation (CDSCO) has granted marketing authorization to AstraZeneca Pharma India Limited for Datopotamab…

Continue ReadingCDSCO Panel Clears AstraZeneca’s Datopotamab for Breast Cancer, Seeks Phase IV Trial

Endocrine Societies Release Joint Recommendations for Safer Pregnancies in Women With Diabetes

USA: A new joint clinical practice guideline from the Endocrine Society and the European Society of Endocrinology, published in The Journal of Clinical Endocrinology & Metabolism, provides critical recommendations to…

Continue ReadingEndocrine Societies Release Joint Recommendations for Safer Pregnancies in Women With Diabetes

Risk for GERD higher with GLP-1 RA use compared to SGLT-2 inhibitor use: Study

A population-based cohort study emulating a target trial estimated the effect of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) compared with sodium-glucose cotransporter-2 (SGLT-2) inhibitors on the risk for gastroesophageal reflux…

Continue ReadingRisk for GERD higher with GLP-1 RA use compared to SGLT-2 inhibitor use: Study

Anticholinergic Use Linked to Faster Physical Decline in Older Adults, finds research

Researchers have found in a new cohort study that higher exposure to anticholinergic medications was associated with an accelerated decline in physical performance. This decline was clinically meaningful, highlighting the…

Continue ReadingAnticholinergic Use Linked to Faster Physical Decline in Older Adults, finds research

Semaglutide and Tirzepatide May Lower Dementia, Stroke, and Death Risk in Diabetic Patients With Obesity: Study

Taiwan: A large-scale cohort study published in JAMA Network Open suggests that the use of GLP-1 receptor agonists, specifically semaglutide and tirzepatide, may offer protective benefits beyond blood sugar control…

Continue ReadingSemaglutide and Tirzepatide May Lower Dementia, Stroke, and Death Risk in Diabetic Patients With Obesity: Study

Stress Hyperglycemia Ratio Identified as Predictor of Early Mortality in Acute CV Disease: Study

A new study published in the journal of BMC Cardiovascular Diabetology revealed that an elevated stress hyperglycemia ratio (SHR) is linked to increased early mortality in cardiovascular disease patients, even…

Continue ReadingStress Hyperglycemia Ratio Identified as Predictor of Early Mortality in Acute CV Disease: Study